Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du CHUQ-CHUL, Laurier, Québec G1V 4G2, Canada.
Arthritis Res Ther. 2009;11(3):R74. doi: 10.1186/ar2703. Epub 2009 May 21.
Osteoarthritis is characterized by the progressive destruction of cartilage in the articular joints. Novel therapies that promote resurfacing of exposed bone in focal areas are of interest in osteoarthritis because they may delay the progression of this disabling disease in patients who develop focal lesions. Recently, the addition of 80% deacetylated chitosan to cartilage microfractures was shown to promote the regeneration of hyaline cartilage. The molecular mechanisms by which chitosan promotes cartilage regeneration remain unknown. Because neutrophils are transiently recruited to the microfracture site, the effect of 80% deacetylated chitosan on the function of neutrophils was investigated. Most studies on neutrophils use preparations of chitosan with an uncertain degree of deacetylation. For therapeutic purposes, it is of interest to determine whether the degree of deacetylation influences the response of neutrophils to chitosan. The effect of 95% deacetylated chitosan on the function of neutrophils was therefore also investigated and compared with that of 80% deacetylated chitosan.
Human blood neutrophils from healthy donors were isolated by centrifugation on Ficoll-Paque. Chemotaxis was performed using the chemoTX system. Production of superoxide anions was evaluated using the cytochrome c reduction assay. Degranulation was determined by evaluating the release of myeloperoxidase and lactoferrin. The internalization of fluorescently labelled 80% deacetylated chitosan by neutrophils was studied by confocal microscopy.
Neutrophils were dose dependently attracted to 80% deacetylated chitosan. In contrast, 95% deacetylated chitosan was not chemotactic for neutrophils. Moreover, the majority of the chemotactic effect of 80% deacetylated chitosan was mediated by phospholipase-A2-derived bioactive lipids. Contrary to the induction of chemotaxis, neither 80% nor 95% deacetylated chitosan activated the release of granule enzymes or the generation of active oxygen species. Despite the distinct response of neutrophils toward 80% and 95% deacetylated chitosan, both chitosans were internalized by neutrophils.
Eighty per cent deacetylated chitosan induces a phenotype in neutrophils that is distinct from the classical phenotype induced by pro-inflammatory agents. Our observations also indicate that the degree of deacetylation is an important factor to consider in the use of chitosan as an accelerator of repair because neutrophils do not respond to 95% deacetylated chitosan.
骨关节炎的特征是关节软骨的进行性破坏。在骨关节炎中,人们对促进局部骨表面再形成的新型疗法很感兴趣,因为这些疗法可能会延缓发生局灶性病变患者疾病的进展。最近,将 80%脱乙酰壳聚糖添加到软骨微骨折中被证明可以促进透明软骨的再生。壳聚糖促进软骨再生的分子机制尚不清楚。由于中性粒细胞会短暂募集到微骨折部位,因此研究了 80%脱乙酰壳聚糖对中性粒细胞功能的影响。大多数关于中性粒细胞的研究都使用脱乙酰度不确定的壳聚糖制剂。为了治疗目的,确定脱乙酰度是否会影响中性粒细胞对壳聚糖的反应是很有意义的。因此,还研究了 95%脱乙酰壳聚糖对中性粒细胞功能的影响,并与 80%脱乙酰壳聚糖进行了比较。
健康供体的人血液中性粒细胞通过在 Ficoll-Paque 上离心分离。使用 chemoTX 系统进行趋化性测定。使用细胞色素 c 还原测定法评估超氧化物阴离子的产生。通过评估髓过氧化物酶和乳铁蛋白的释放来确定脱颗粒。通过共聚焦显微镜研究荧光标记的 80%脱乙酰壳聚糖被中性粒细胞内化的情况。
中性粒细胞呈剂量依赖性地被 80%脱乙酰壳聚糖吸引。相比之下,95%脱乙酰壳聚糖对中性粒细胞没有趋化性。此外,80%脱乙酰壳聚糖的趋化作用主要是由磷脂酶 A2 衍生的生物活性脂质介导的。与趋化作用的诱导相反,80%和 95%脱乙酰壳聚糖都不会激活颗粒酶的释放或活性氧的产生。尽管中性粒细胞对 80%和 95%脱乙酰壳聚糖的反应不同,但两种壳聚糖都被中性粒细胞内化。
80%脱乙酰壳聚糖诱导中性粒细胞呈现出与经典的促炎剂诱导的表型不同的表型。我们的观察结果还表明,在将壳聚糖用作修复促进剂时,脱乙酰度是一个重要的考虑因素,因为中性粒细胞对 95%脱乙酰壳聚糖没有反应。